Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux
NCT00414856
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
34
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastroesophageal Reflux Disease
Interventions
DRUG:
AFQ056
Sponsor
Novartis